文献速递血栓与止血

重症COVID-19中VWF/ADAMTS13轴失衡是强烈炎症和内皮损伤的生物标志物而非血栓驱动因素

Imbalance of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically ill COVID-19 patients.
PubMed 文献 · J Thromb Haemost · 2021-07-27

结果显示VWF抗原升高而ADAMTS13活性正常或轻度降低,VWF/ADAMTS13比值升高与死亡率相关,所有患者ADAMTS13均为闭合构象,提示该轴失衡反映炎症和内皮损伤而非血栓驱动。

要点

  • 重症COVID-19患者VWF/ADAMTS13比值升高与死亡率相关。
  • ADAMTS13活性正常或轻度降低,无严重缺乏或TTP特征。
  • 所有患者ADAMTS13为闭合构象,不支持免疫介导TTP机制。

核心结论

  • VWF/ADAMTS13轴失衡是反映强烈炎症和内皮损伤的生物标志物,而非COVID-19血栓过程的驱动因素。

主要发现

  • 中位年龄59岁,男女比2.8/1,报告7例肺栓塞和15例死亡。
  • 纤维蛋白原和因子V水平升高,D-二聚体显著升高且与死亡率相关。
  • 无患者出现严重血小板减少或微血管病性溶血性贫血。
  • VWF抗原升高而ADAMTS13活性正常或轻度降低,VWF/ADAMTS13比值显著升高且与死亡率相关。
  • 3例患者存在ADAMTS13部分数量缺陷,所有患者ADAMTS13为闭合构象。

临床怎么用

  • 重症COVID-19中VWF/ADAMTS13轴失衡不宜作为血栓性微血管病或TTP的诊断依据。
  • VWF/ADAMTS13比值升高提示炎症和内皮损伤,可辅助评估病情严重程度。

局限性

  • 单中心小样本研究,结论需更大规模研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Critically ill patients with coronavirus disease 2019 (COVID-19) are prone to developing macrothrombosis and microthrombosis. COVID-19 has been reported to be rarely associated with thrombotic microangiopathies. A disintegrin and metalloprotease with thrombospondin type I repeats, member 13 (ADAMTS13) severe deficiency, the hallmark of thrombotic thrombocytopenic purpura (TTP), induces the formation of platelet, unusually large von Willebrand factor (VWF) multimer microthrombi. In immune-mediated TTP, ADAMTS13 adopts specifically an open conformation. The VWF/ADAMTS13 couple may contribute to the microthrombi formation in pulmonary alveolar capillaries in COVID-19. OBJECTIVE: To investigate clinical features, hemostatic laboratory parameters, VWF/ADAMTS13 axis, and ADAMTS13 conformation in critically ill COVID-19 patients at admission. METHODS: Fifty three critically ill COVID-19 patients were enrolled between March 18 and May 9 2020 in a monocentric hospital. RESULTS: The median age was 59 years and the male-to-female ratio was 2.8/1. We reported seven pulmonary embolisms and 15 deaths. Biological investigations showed increased fibrinogen and factor V levels, and strongly increased D-dimers correlated with mortality. No patient presented severe thrombocytopenia nor microangiopathic hemolytic anemia. An imbalance between high VWF antigen levels and normal or slightly decreased ADAMTS13 activity levels (strongly elevated VWF/ADAMTS13 ratio) was correlated with mortality. Three patients had a partial quantitative deficiency in ADAMTS13. We also reported a closed conformation of ADAMTS13 in all patients, reinforcing the specificity of an open conformation of ADAMTS13 as a hallmark of TTP. CONCLUSION: We suggest that slightly decreased or normal ADAMTS13 activity and highly elevated VWF are rather biomarkers reflecting both the strong inflammation and the endothelial damage rather than drivers of the thrombotic process of COVID-19.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Joly BS, Darmon M, Dekimpe C, et al. Imbalance of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically ill COVID-19 patients. J Thromb Haemost. 2021. PMID: 34219357. doi:10.1111/jth.15445

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。